日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New Guinea

在巴布亚新几内亚东新不列颠省,采用伊维菌素、乙胺嗪和阿苯达唑进行大规模药物治疗后,监测和评估淋巴丝虫病的替代方法

Bun, Krufinta; Mode, Benedict; Susapu, Melinda; Salo, Joyceline; Bjerum, Catherine; Payne, Michael; Tisch, Daniel; Sekihara, Makoto; Giorgi, Emanuele; Weil, Gary J; Fischer, Peter U; Robinson, Leanne; Laman, Moses; King, Christopher L

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination.

Wb5 是一种新型生物标志物,用于监测大规模药物管理计划消除班氏丝虫病的疗效和成功率

Pietrow Rachel E, Bjerum Catherine, Koudou Benjamin G, Supali Taniawati, Budge Philip J, Fischer Peter U, Nutman Thomas B, Bennuru Sasisekhar

Implementation and Outcomes of a Pilot Collaborative Surgical Hydrocele Training in Côte d'Ivoire

科特迪瓦试点合作式鞘膜积液外科培训的实施及成果

Montes, Kevin; Angoa, Georgina; Bjerum, Catherine M; Guira, Adama; Kouadio, Olivier K; Ouattara, Allassane F; Weil, Gary J; Fischer, Peter U; Meite, Aboulaye; Koudou, Benjamin G; Budge, Philip J

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study

在科特迪瓦,莫昔克汀和伊维菌素联合治疗淋巴丝虫病的安全性和耐受性:一项随机对照优效性研究

Bjerum, Catherine M; Koudou, Benjamin G; Ouattara, Allassane F; Lew, Daphne; Goss, Charles W; Gabo, Pascal T; King, Christopher L; Fischer, Peter U; Weil, Gary J; Budge, Philip J

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis

伊维菌素在淋巴丝虫病大规模给药中的群体药代动力学模型

Alshehri, Abdullah; Chhonker, Yashpal S; Bala, Veenu; Edi, Constant; Bjerum, Catherine M; Koudou, Benjamin G; John, Lucy N; Mitjà, Oriol; Marks, Michael; King, Christopher L; Murry, Daryl J

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis

莫西克丁与阿苯达唑及阿苯达唑与乙胺嗪联合治疗班克罗夫特丝虫病的药代动力学

Yashpal S Chhonker, Catherine Bjerum, Veenu Bala, Allassane F Ouattara, Benjamin G Koudou, Toki P Gabo, Abdullah Alshehri, Abdoulaye Meïté, Peter U Fischer, Gary J Weil, Christopher L King, Philip J Budge, Daryl J Murry

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

在巴布亚新几内亚,采用单剂量三联药物(阿苯达唑+乙胺嗪+伊维菌素)进行大规模药物治疗淋巴丝虫病的安全性和有效性:一项开放标签、整群随机试验

Tavul, Livingstone; Laman, Moses; Howard, Cade; Kotty, Bethuel; Samuel, Anna; Bjerum, Catherine; O'Brian, Kobie; Kumai, Steven; Amuga, Matthew; Lorry, Lina; Kerry, Zebedee; Kualawi, Melvin; Karl, Stephan; Makita, Leo; John, Lucy N; Bieb, Sibauk; Wangi, James; Weil, Gary J; Goss, Charles W; Tisch, Daniel J; Pomat, William; King, Christopher L; Robinson, Leanne J

A simple, high-throughput and validated LC-MS/MS method for the determination of azithromycin in human plasma and its application to a clinical pharmacokinetic study

一种简单、高通量且经过验证的 LC-MS/MS 方法,用于测定人血浆中的阿奇霉素及其在临床药代动力学研究中的应用

Yuning Zhang, Veenu Bala, Yashpal S Chhonker, Wafaa N Aldhafiri, Lucy N John, Catherine M Bjerum, Christopher L King, Oriol Mitja, Michael Marks, Daryl J Murry

Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals

二乙胺嗪在淋巴丝虫病患者和健康个体中的群体药代动力学

Bala, Veenu; Chhonker, Yashpal S; Alshehri, Abdullah; Edi, Constant; Bjerum, Catherine M; Koudou, Benjamin G; King, Christopher L; Murry, Daryl J

Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial

伊维菌素、乙胺嗪和阿苯达唑单剂量治疗科特迪瓦淋巴丝虫病的疗效和安全性:一项开放标签随机对照试验

Bjerum, Catherine M; Ouattara, Allassane F; Aboulaye, Méité; Kouadio, Olivier; Marius, Vanga K; Andersen, Britt J; Weil, Gary J; Koudou, Benjamin G; King, Christopher L